Skip Navigation
Return to All Schools

Sol Goldman Professorship in Pancreatic Cancer Research

School of Medicine

Established in 2015 by the Department of Pathology in honor of the Goldman Family

Drawn to Johns Hopkins when their mother Lillian passed away from pancreatic cancer, the Goldman Family of New York decided to take action against the disease that took their mother’s life.

In 2005, they endowed the Sol Goldman Pancreatic Cancer Research Center in the Department of Pathology at Johns Hopkins, named after their father SOL GOLDMAN, a self-made real estate investor who became the single largest private landlord in New York City. Since its inception, the Goldman Center has funded more than 100 grant proposals, which have benefitted 41 principal investigators from 16 departments across the Johns Hopkins University.

The Sol Goldman Professorship in Pancreatic Cancer Research honors the Goldman Family for their generosity and tireless effort to improve diagnosis and treatment options for patients through innovative research in pancreatic cancer.

Held by Michael G. Goggins

MICHAL G. GOGGINS, M.B., M.D., the Sol Goldman Professor in Pancreatic Cancer Research, received his undergraduate and medical degrees from Trinity College at the University of Dublin in 1988. Between 1988 and 1995, Dr. Goggins completed both his internship and residency in internal medicine, as well as his fellowship training in gastroenterology and internal medicine, at St. James’s Hospital in Dublin. He held a position as lecturer in Clinical Medicine at Trinity College Dublin from 1992 to 1995.

In 1995, Dr. Goggins returned to the United States and came to the Johns Hopkins School of Medicine to complete a research fellowship in the Department of Pathology’s Division of Gastrointestinal Pathology and a clinical fellowship in gastroenterology in the Department of Medicine’s Gastrointestinal Division. In 1997, he was awarded his doctoral degree by Trinity College Dublin. In 1998, Dr. Goggins worked as a research associate in the Department of Oncology at Johns Hopkins before joining the faculty in 1999 as an instructor in pathology and oncology. That same year, he established the Pancreatic Cancer Early Detection Research Laboratory and was promoted to Assistant Professor of Pathology and Oncology. In 2000, Dr. Goggins was appointed to the faculty of the Johns Hopkins Department of Medicine as an assistant professor, before being elevated to Associate Professor in Pathology, Medicine and Oncology in 2003. In 2008, he was promoted to Professor of Pathology, Medicine and Oncology.

Dr. Goggins is a member of the faculty in the Johns Hopkins Division of Gastrointestinal/Liver Pathology in the Department of Pathology, and is an attending physician in the Division of Gastroenterology/Hepatology in the Department of Medicine and in the Oncology Center. Dr. Goggins has written or co-authored more than 250 peer-reviewed publications and authored more than two dozen book chapters. In 2007, he was named by Thomson Reuters Essential Science Indicators as the sixth most highly cited pancreatic cancer scientist over the past decade. He is a member of the Scientific Advisory Board of the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins and has served on numerous national advisory committees on pancreatic cancer.

As a member of the pancreatic cancer research team at Johns Hopkins, Dr. Goggins was recognized in 2012 by the American Association for Cancer Research with the Team Science Award. He is the principal investigator of the Cancer of the Pancreas Screening (“CAPS”) multicenter study which is supported by a Research Acceleration Award from the Pancreatic Cancer Action Network and an R01 grant from the National Cancer Institute. Dr. Goggins is also an investigator for the Johns Hopkins Specialized Program in Research Excellence for Gastrointestinal Cancer.